Mehren Lawrence 4
4 · Accelerate Diagnostics, Inc · Filed Aug 18, 2017
Insider Transaction Report
Form 4
Mehren Lawrence
DirectorCEO10% Owner
Transactions
- Sale
Common Stock
2017-08-17$22.40/sh−223,215$5,000,016→ 762,381 total
Holdings
- 52,132
Employee Stock Option (right to buy)
Exercise: $14.92From: 2015-02-26Exp: 2024-02-26→ Common Stock - 10,408
Employee Stock Option (right to buy)
Exercise: $12.49From: 2017-03-18Exp: 2026-03-18→ Common Stock - 60,000
Employee Stock Option (right to buy)
Exercise: $12.49Exp: 2026-03-18→ Common Stock - 2,200,000
Employee Stock Option (right to buy)
Exercise: $1.04Exp: 2022-04-20→ Common Stock
Footnotes (4)
- [F1]The reporting person contributed AXDX common stock to an exchange fund in exchange for shares of the exchange fund. The AXDX common stock was valued at $22.40 per share for the purposes of determining the number of shares of the exchange fund issuable to the reporting person. The shares were contributed pursuant to a Rule 10b5-1 plan entered into by the reporting person.
- [F2]No transaction is being reported at this time. This line is only reporting holdings as of the date hereof.
- [F3]The options vest in five (5) equal annual installments on each annivesary of the date of grant beginning on March 18, 2017.
- [F4]580,000 shares vested immediately upon the date of grant (April 20, 2012); 825,000 shares will vest as follows: 40% (330,000 shares) will vest on the second anniversary of the date of grant, and the remaining 60% (495,000 shares) will vest in 36 equal monthly installments (13,750 shares per month) over the subsequent 36 months; and 795,000 shares will vest as follows (provided that both criteria must be satisfied): (i) 40% (318,000 shares) will vest on the second anniversary of the date of grant, and the remaining 60% (477,000 shares) will vest in 36 equal monthly installments (13,250 shares per month) over the subsequent 36 months, and (ii) 50% (397,500 shares) will vest when at least 50% of the warrants initially issued to Abeja have been exercised by the holder(s) thereof, and the remaining 50% (397,500 shares) will vest when at least 90% of such warrants have been exercised by the holder(s) thereof.